Mycenax Biotech Inc. (TPEX:4726)

Mycenax Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,148	8,967	7,350	7,699	5,811	4,129
Market Cap Growth	-19.54%	22.00%	-4.53%	32.48%	40.74%	38.50%
Enterprise Value	8,051	9,481	7,281	8,353	5,998	3,966
Last Close Price	34.50	43.40	35.70	37.50	37.90	32.20
PE Ratio	-	-	-	-	-	133.43
PS Ratio	11.00	13.11	11.26	10.51	7.51	6.21
PB Ratio	4.35	4.43	3.00	2.48	3.05	3.41
P/TBV Ratio	4.44	4.51	3.06	2.52	3.14	3.59
P/OCF Ratio	-	-	-	-	-	23.71
EV/Sales Ratio	12.39	13.86	11.16	11.41	7.75	5.96
EV/EBITDA Ratio	-	-	-	-	135.32	26.30
EV/EBIT Ratio	-	-	-	-	-	112.05
Debt / Equity Ratio	0.68	0.44	0.30	0.31	0.39	0.16
Debt / EBITDA Ratio	-	-	-	-	9.96	1.15
Asset Turnover	0.19	0.19	0.16	0.19	0.32	0.42
Inventory Turnover	9.98	10.44	5.73	4.03	4.93	6.79
Quick Ratio	0.38	0.64	0.97	2.24	1.15	1.10
Current Ratio	0.75	1.11	1.46	3.03	1.66	1.36
Return on Equity (ROE)	-25.64%	-20.90%	-24.59%	-18.10%	-5.76%	2.67%
Return on Assets (ROA)	-8.14%	-8.08%	-9.15%	-7.33%	-2.18%	1.40%
Return on Capital Employed (ROCE)	-19.70%	-17.10%	-20.00%	-11.70%	-3.30%	2.70%
Earnings Yield	-6.71%	-5.21%	-9.29%	-5.89%	-1.55%	0.75%
FCF Yield	-4.10%	-5.82%	-5.81%	-10.09%	-21.41%	-2.08%
Buyback Yield / Dilution	-0.52%	-0.23%	-24.31%	-11.35%	-15.36%	-2.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.